These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 23077290)

  • 1. Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study.
    Grosse-Sundrup M; Henneman JP; Sandberg WS; Bateman BT; Uribe JV; Nguyen NT; Ehrenfeld JM; Martinez EA; Kurth T; Eikermann M
    BMJ; 2012 Oct; 345():e6329. PubMed ID: 23077290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate-Acting Nondepolarizing Neuromuscular Blocking Agents and Risk of Postoperative 30-Day Morbidity and Mortality, and Long-term Survival.
    Bronsert MR; Henderson WG; Monk TG; Richman JS; Nguyen JD; Sum-Ping JT; Mangione MP; Higley B; Hammermeister KE
    Anesth Analg; 2017 May; 124(5):1476-1483. PubMed ID: 28244947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study.
    Saager L; Maiese EM; Bash LD; Meyer TA; Minkowitz H; Groudine S; Philip BK; Tanaka P; Gan TJ; Rodriguez-Blanco Y; Soto R; Heisel O
    J Clin Anesth; 2019 Aug; 55():33-41. PubMed ID: 30594097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of neostigmine reversal of nondepolarizing neuromuscular blocking agents on postoperative respiratory outcomes: a prospective study.
    Sasaki N; Meyer MJ; Malviya SA; Stanislaus AB; MacDonald T; Doran ME; Igumenshcheva A; Hoang AH; Eikermann M
    Anesthesiology; 2014 Nov; 121(5):959-68. PubMed ID: 25225821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of complications in the post-anesthesia care unit and associated healthcare utilization in patients undergoing non-cardiac surgery requiring neuromuscular blockade 2005-2013: A single center study.
    Belcher AW; Leung S; Cohen B; Yang D; Mascha EJ; Turan A; Saager L; Ruetzler K
    J Clin Anesth; 2017 Dec; 43():33-38. PubMed ID: 28972924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-dependent Association between Intermediate-acting Neuromuscular-blocking Agents and Postoperative Respiratory Complications.
    McLean DJ; Diaz-Gil D; Farhan HN; Ladha KS; Kurth T; Eikermann M
    Anesthesiology; 2015 Jun; 122(6):1201-13. PubMed ID: 25919486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of muscle function after deep neuromuscular block by means of diaphragm ultrasonography and adductor of pollicis acceleromyography with comparison of neostigmine vs. sugammadex as reversal drugs: study protocol for a randomized controlled trial.
    Cappellini I; Picciafuochi F; Ostento D; Danti G; De Gaudio AR; Adembri C
    Trials; 2018 Feb; 19(1):135. PubMed ID: 29467022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nondepolarizing Neuromuscular Blocking Agents, Reversal, and Risk of Postoperative Pneumonia.
    Bulka CM; Terekhov MA; Martin BJ; Dmochowski RR; Hayes RM; Ehrenfeld JM
    Anesthesiology; 2016 Oct; 125(4):647-55. PubMed ID: 27496656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The RECITE Study: A Canadian Prospective, Multicenter Study of the Incidence and Severity of Residual Neuromuscular Blockade.
    Fortier LP; McKeen D; Turner K; de Médicis É; Warriner B; Jones PM; Chaput A; Pouliot JF; Galarneau A
    Anesth Analg; 2015 Aug; 121(2):366-72. PubMed ID: 25902322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of rocuronium neuromuscular block using a protocol for qualitative monitoring and reversal with neostigmine.
    Thilen SR; Ng IC; Cain KC; Treggiari MM; Bhananker SM
    Br J Anaesth; 2018 Aug; 121(2):367-377. PubMed ID: 30032875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tactile evaluation of the response to double burst stimulation decreases, but does not eliminate, the problem of postoperative residual paralysis.
    Fruergaard K; Viby-Mogensen J; Berg H; el-Mahdy AM
    Acta Anaesthesiol Scand; 1998 Nov; 42(10):1168-74. PubMed ID: 9834799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis.
    Kheterpal S; Vaughn MT; Dubovoy TZ; Shah NJ; Bash LD; Colquhoun DA; Shanks AM; Mathis MR; Soto RG; Bardia A; Bartels K; McCormick PJ; Schonberger RB; Saager L
    Anesthesiology; 2020 Jun; 132(6):1371-1381. PubMed ID: 32282427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
    Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
    Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of sugammadex vs. neostigmine on postoperative respiratory complications and advanced healthcare utilisation: a multicentre retrospective cohort study.
    Suleiman A; Munoz-Acuna R; Azimaraghi O; Houle TT; Chen G; Rupp S; Witt AS; Azizi BA; Ahrens E; Shay D; Wongtangman K; Wachtendorf LJ; Tartler TM; Eikermann M; Schaefer MS
    Anaesthesia; 2023 Mar; 78(3):294-302. PubMed ID: 36562202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial.
    Nemes R; Fülesdi B; Pongrácz A; Asztalos L; Szabó-Maák Z; Lengyel S; Tassonyi E
    Eur J Anaesthesiol; 2017 Sep; 34(9):609-616. PubMed ID: 28030444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence of residual neuromuscular blockade associated with single dose of intermediate-acting neuromuscular blocking drugs.
    Kaan N; Kocaturk O; Kurt I; Cicek H
    Middle East J Anaesthesiol; 2012 Feb; 21(4):535-41. PubMed ID: 23327026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
    Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
    Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a new strategy to improve the peri-operative management of neuromuscular blockade and its effects on postoperative pulmonary complications.
    Rudolph MI; Chitilian HV; Ng PY; Timm FP; Agarwala AV; Doney AB; Ramachandran SK; Houle TT; Eikermann M
    Anaesthesia; 2018 Sep; 73(9):1067-1078. PubMed ID: 29974459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.